Product Information
FLUTICASONE PROPIONATE HFA 110 MCG INHALER is a generic product labeled by Prasco Laboratories, priced at $13.5915 per GM under NDC 66993007996. Its NADAC has been published 216 times since Aug 17, 2022.
FDA first approved this application on May 14, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the fluticasone propionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
110 ug/1
Manufacturer
Prasco LaboratoriesNDC
66993007996
Classification
Generic
Dosage Form
AEROSOL, METERED
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
FLUTICASONE PROPIONATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021433FDA Approved
5/14/2004
TE Code
AB
On Market Since
5/23/2022
Pharmacological Classes
Price Statistics
The NADAC for FLUTICASONE PROPIONATE HFA 110 MCG INHALER has been published 216 times since Aug 17, 2022, and over the history we have for it it has declined 2.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.5915 per GM |
|---|---|
| All-time high | $14.1208 (Sep 13, 2023) |
| All-time low | $12.8322 (Jul 17, 2024) |
| 52-week high | $13.6595 |
| 52-week low | $13.5117 |
| Median price | $13.5994 |
| Average price | $13.6138 |
| Largest weekly change | -6.9% (Jul 17, 2024) |
| Weeks tracked | 216 |
| Tracking since | Aug 17, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fluticasone propionate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Prasco Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluticasone propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUTICASONE PROPIONATE HFA 110 MCG INHALER?
The current National Average Drug Acquisition Cost (NADAC) for FLUTICASONE PROPIONATE HFA 110 MCG INHALER, manufactured by Prasco Laboratories, is $13.5915 per GM (NDC 66993007996), effective Sep 30, 2026.
How has the price of FLUTICASONE PROPIONATE HFA 110 MCG INHALER changed over time?
Over the history we have for it, the NADAC for FLUTICASONE PROPIONATE HFA 110 MCG INHALER has declined 2.8%. It has been tracked across 216 weekly CMS publications since Aug 17, 2022.
What are the highest and lowest recorded NADAC prices for FLUTICASONE PROPIONATE HFA 110 MCG INHALER?
Since Aug 17, 2022, the NADAC for FLUTICASONE PROPIONATE HFA 110 MCG INHALER has ranged from a low of $12.8322 (Jul 17, 2024) to a high of $14.1208 (Sep 13, 2023), with a median of $13.5994 per GM.
Are there cheaper alternatives to FLUTICASONE PROPIONATE HFA 110 MCG INHALER?
No other NADAC-published product currently shares the active ingredient and strength of FLUTICASONE PROPIONATE HFA 110 MCG INHALER in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLUTICASONE PROPIONATE HFA 110 MCG INHALER?
FLUTICASONE PROPIONATE HFA 110 MCG INHALER (NDC 66993007996) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.